K

Researcher Profile

Kai Chu

4

Publications

1,641

Citations

10

Co-Authors

4

Active Years

Publications

Open Access Journal Article Science Bulletin Oct 01, 2023

Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial

Yue-Mei Hu · Zhao-Feng Bi · Ya Zheng · Li Zhang +23 more

10.1016/j.scib.2023.09.020 26 citations

Journal Article The Lancet Infectious Diseases Feb 01, 2021

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang · Gang Zeng · Hongxing Pan · Chuan Li +16 more

10.1016/s1473-3099(20)30843-4 1,190 citations

Journal Article The Journal of Infectious Diseases Oct 17, 2016

2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study

Mingwei Wei · Fanyue Meng · Jingxin Li · Yuntao Zhang +10 more

10.1093/infdis/jiw502 64 citations

Journal Article The Lancet Jun 01, 2013

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Feng-Cai Zhu · Fan-Yue Meng · Jing-Xin Li · Xiu-Ling Li +27 more

10.1016/s0140-6736(13)61049-1 361 citations

Publication Timeline

2023

1

2021

1

2016

1

2013

1

Frequent Co-Authors